(Press-News.org)
The prevalence of remote work since the start of the Covid-19 pandemic has significantly changed urban transportation patterns in the U.S., according to new study led by MIT researchers.
The research finds significant variation between the effects of remote work on vehicle miles driven and on mass-transit ridership across the U.S.
“A 1 percent decrease in onsite workers leads to a roughly 1 percent reduction in [automobile] vehicle miles driven, but a 2.3 percent reduction in mass transit ridership,” says Yunhan Zheng SM ’21, PhD ’24, an MIT postdoc who is co-author of the study.
“This is one of the first studies that identifies the causal effect of remote work on vehicle miles traveled and transit ridership across the U.S.,” adds Jinhua Zhao, an MIT professor and another co-author of the paper.
By accounting for many of the nuances of the issue, across the lower 48 states and the District of Columbia as well as 217 metropolitan areas, the scholars believe they have arrived at a robust conclusion demonstrating the effects of working from home on larger mobility patterns.
The paper, “Impacts of remote work on vehicle miles traveled and transit ridership in the USA,” appears today in the journal Nature Cities. The authors are Zheng, a doctoral graduate of MIT’s Department of Civil and Environmental Engineering and a postdoc at the Singapore–MIT Alliance for Research and Technology (SMART); Shenhao Wang PhD ’20, an assistant professor at the University of Florida; Lun Liu, an assistant professor at Peking University; Jim Aloisi, a lecturer in MIT’s Department of Urban Studies and Planning (DUSP); and Zhao, the Professor of Cities and Transportation, founder of the MIT Mobility Initiative, and director of MIT’s JTL Urban Mobility Lab and Transit Lab.
The researchers gathered data on the prevalence of remote work from multiple sources, including Google location data, travel data from the U.S. Federal Highway Administration and the National Transit Database, and the monthly U.S. Survey of Working Arrangements and Attitudes (run jointly by Stanford University, the University of Chicago, ITAM, and MIT).
The study reveals significant variation among U.S. states when it comes to how much the rise of remote work has affected mileage driven.
“The impact of a 1 percent change in remote work on the reduction of vehicle miles traveled in New York state is only about one-quarter of that in Texas,” Zheng observes. “There is real variation there.”
At the same time, remote work has had the biggest effect on mass-transit revenues in places with widely used systems, with New York City, Chicago, San Francisco, Boston, and Philadelphia making up the top five hardest-hit metro areas.
The overall effect is surprisingly consistent over time, from early 2020 through late 2022.
“In terms of the temporal variation, we found that the effect is quite consistent across our whole study period,” Zheng says. “It’s not just significant in the early stage of the pandemic, when remote work was a necessity for many. The magnitude remains consistent into the later period, when many people have the flexibility to choose where they want to work. We think this may have long-term implications.”
Additionally, the study estimates the impact that still larger numbers of remote workers could have on the environment and mass transit.
“On a national basis, we estimate that a 10 percent decrease in the number of onsite workers compared to pre-pandemic levels will reduce the annual total vehicle-related CO2 emissions by 191.8 million metric tons,” Wang says.
The study also projects that across the 217 metropolitan areas in the study, a 10 percent decrease in the number of onsite workers, compared to pre-pandemic levels, would lead to an annual loss of 2.4 billion transit trips and $3.7 billion in fare revenue — equal to roughly 27 percent of the annual transit ridership and fare revenue in 2019.
“The substantial influence of remote work on transit ridership highlights the need for transit agencies to adapt their services accordingly, investing in services tailored to non-commuting trips and implementing more flexible schedules to better accommodate the new demand patterns,” Zhao says.
The research received support from the MIT Energy Initiative; the Barr Foundation; the National Research Foundation, Prime Minister’s Office, Singapore under its Campus for Research Excellence and Technological Enterprise program; the Research Opportunity Seed Fund 2023 from the University of Florida; and the Beijing Social Science Foundation.
###
Written by Peter Dizikes, MIT News
Paper: “Impacts of remote work on vehicle miles traveled and transit ridership in the USA”
https://www.nature.com/articles/s44284-024-00057-1
END
Irvine, Calif., April 9, 2024 — A University of California, Irvine-led team reveals a clear link between human-driven climate change and the years-long drought currently gripping southern Madagascar. Their study appears in the Nature journal Climate and Atmospheric Science.
“Using remotely sensed observations and climate models, we could see evidence that climate change is affecting the hydrological cycle in southern Madagascar, and it’s likely going to have big implications for the people that live there and how they grow their food,” ...
“[...] CMS121 applicability could be expanded from a geroneuroprotector drug to a metabolic drug [...]”
BUFFALO, NY- April 9, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 6, entitled, “CMS121: a novel approach to mitigate aging-related obesity and metabolic dysfunction.”
Modulated by differences in genetic and environmental factors, laboratory mice often show progressive weight gain, eventually leading to obesity and metabolic dyshomeostasis. ...
About 90% of deaths from cancer are a result of metastasis — that is, from cancer’s ability to spread from an initial primary tumor to seed new tumors throughout the body, often in the lungs, liver, and brain.
And metastasis relies on cancer cells’ ability to adapt to different tissue environments throughout the body by gaining improper access to a variety of playbooks stored in our genetic code — including gene programs that are generally available only during early stages of human development.
Today, researchers at Memorial Sloan Kettering Cancer Center (MSK) are using innovative approaches like single-cell sequencing technology ...
Vancouver, BC – The Canadian Neuromodulation Society and the International Neuromodulation Society (INS) are delighted to announce a public education event, "Understanding Neuromodulation of the Brain and Spinal Cord”.
This complimentary event is scheduled to take place at the Vancouver Convention Centre, East Building, on Saturday, May 11, from 13:30 to 18:00, during the 16th INS World Congress.
Aimed at patients, their families, and friends dealing with conditions such as chronic pain, Parkinson’s disease, and tremor, this event is ...
SAN ANTONIO — April 9, 2024 — Southwest Research Institute has invested in new space robotics capabilities to help the space industry pave the way for in-space servicing, assembly and manufacturing (ISAM) capabilities. SwRI’s Intelligent Systems Division will demonstrate new ISAM-focused research at the 38th Space Symposium, April 8-11, in Colorado Springs. Visit SwRI at Booth #237.
“SwRI is developing solutions to leverage Earth-based industrial robotics with advanced automation and simulation so we can help clients develop new capabilities for the complex conditions ...
April 9, 2024, Cleveland: New findings from Cleveland Clinic and Tufts University researchers show high blood levels of TMAO (trimethylamine N-oxide) predicts future risk of developing chronic kidney disease over time.
The findings build on more than a decade of research spearheaded by Stanley Hazen, M.D., Ph.D., and a team related to the gut microbiome’s role in cardiovascular health and disease, including the adverse effects of TMAO, a byproduct formed by the gut bacteria from nutrients abundant in red meat, eggs and other animal source foods.
The study, published in the Journal of the American Society of Nephrology, was a collaboration ...
New Orleans, LA – Ochsner Health is proud to bring an advancement in the treatment of heart rhythm disorders to the New Orleans and Gulf South region utilizing a new cardiac ablation procedure, the FARAPULSE™ Pulsed Field Ablation System. The innovative procedure was performed at the John Ochsner Heart & Vascular Institute, a frontrunner in cardiology that continues to set the standard for cardiovascular care through its commitment to pioneering breakthrough therapies.
With the estimated number of individuals affected by atrial fibrillation predicted to rise to 12.1 million in the United States by 2030 according to the CDC, the introduction of this new treatment ...
Genetic studies of diseases map segments of the genome driving disease. But to understand how those changes contribute to disease progression, it is important to understand how they may alter gene regulation of disease genes in cell populations assumed to be driving disease. “Enhancer-gene maps” link genomic regulatory regions to genes and are essential for understanding disease. But constructing them poses challenges due to limitations in current experimental methods, that make it difficult to apply the technique to rare cell populations and genes that ...
We all lose our car keys or our glasses from time to time. Most people would be correct to laugh it off as a normal part of aging. But for others, cognitive decline may start as a worrying but clinically unnoticeable step toward cognitive impairment, be it relatively mild or as severe as Alzheimer’s disease.
The vast complexity of the human brain makes early diagnosis of cognitive decline difficult to achieve, which has potentially important implications for treatment and prevention. This is especially true ...
A clinical trial led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heart rhythms. The study, published March 25 in the Journal of the American College of Cardiology, provides real-world evidence that a wide range of patients can safely and effectively use the experimental drug, called etripamil, to treat recurrent paroxysmal supraventricular ...
